218 related articles for article (PubMed ID: 20055560)
1. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
2. Current issues in the histopathology of gestational trophoblastic tumors.
Sebire NJ; Lindsay I
Fetal Pediatr Pathol; 2010; 29(1):30-44. PubMed ID: 20055562
[TBL] [Abstract][Full Text] [Related]
3. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
4. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
5. Current management of complete and partial molar pregnancy.
Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
[TBL] [Abstract][Full Text] [Related]
6. Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy.
Sebire NJ; Makrydimas G; Agnantis NJ; Zagorianakou N; Rees H; Fisher RA
Anticancer Res; 2003; 23(2C):1723-8. PubMed ID: 12820448
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
8. Current management of gestational trophoblastic diseases.
Berkowitz RS; Goldstein DP
Gynecol Oncol; 2009 Mar; 112(3):654-62. PubMed ID: 18851873
[TBL] [Abstract][Full Text] [Related]
9. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY
Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675
[TBL] [Abstract][Full Text] [Related]
10. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
11. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
12. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
Hancock BW; Nazir K; Everard JE
J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
[TBL] [Abstract][Full Text] [Related]
13. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
14. Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.
Massardier J; Golfier F; Journet D; Frappart L; Zalaquett M; Schott AM; Lenoir VT; Dupuis O; Hajri T; Raudrant D
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):84-7. PubMed ID: 19193484
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit.
Fisher RA; Tommasi A; Short D; Kaur B; Seckl MJ; Sebire NJ
J Clin Pathol; 2014 Nov; 67(11):980-4. PubMed ID: 25078332
[TBL] [Abstract][Full Text] [Related]
16. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of histopathology and DNA image analysis in the diagnosis of molar and non-molar abortion: a study of 89 cases in the center of Tunisia.
Landolsi H; Missaoui N; Yacoubi MT; Trabelsi A; Rammeh-Rommani S; Hidar S; Gribaa M; Hmissa S; Mokni M
Pathol Res Pract; 2009; 205(11):789-96. PubMed ID: 19665315
[TBL] [Abstract][Full Text] [Related]
18. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
19. The pathology of gestational trophoblastic disease: recent advances.
Wells M
Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
